| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 38.265 | 59.383 | 44.240 | 31.249 | 853 | 49.325 | 37.388 | 32.105 | 24.811 | 8.126 |
| Total Income - EUR | 38.297 | 59.389 | 44.240 | 31.444 | 960 | 49.373 | 37.424 | 32.120 | 24.811 | 8.126 |
| Total Expenses - EUR | 11.193 | 12.895 | 6.392 | 5.074 | 1.060 | 9.500 | 6.414 | 7.453 | 14.122 | 4.634 |
| Gross Profit/Loss - EUR | 27.105 | 46.494 | 37.848 | 26.370 | -100 | 39.872 | 31.010 | 24.667 | 10.689 | 3.492 |
| Net Profit/Loss - EUR | 25.956 | 44.712 | 36.520 | 25.426 | -129 | 38.480 | 29.910 | 23.889 | 10.446 | 3.005 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sempre Gyn Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 3.571 | 4.121 | 5.019 | 3.514 | 2.486 | 1.740 |
| Current Assets | 53.129 | 45.144 | 49.080 | 25.684 | 8.213 | 34.731 | 25.373 | 23.160 | 11.989 | 3.435 |
| Inventories | 0 | 0 | 0 | 0 | 497 | 0 | 0 | 0 | 0 | 168 |
| Receivables | 18.957 | 8.424 | 25.008 | 13.109 | 3.096 | 22.843 | 16.064 | 21.316 | 11.107 | 2.918 |
| Cash | 34.172 | 36.720 | 24.072 | 12.575 | 4.620 | 11.889 | 9.309 | 1.844 | 882 | 349 |
| Shareholders Funds | 52.552 | 44.980 | 48.428 | 25.684 | 124 | 38.601 | 30.152 | 24.132 | 10.689 | 5.074 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 578 | 164 | 652 | 0 | 11.660 | 251 | 240 | 2.542 | 3.786 | 101 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sempre Gyn Medical Srl